- Home
- MERC vs PRQR Comparison
MERC vs PRQR Comparison
Compare MERC & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MERC
- PRQR
- Stock Information
- Founded
- MERC 1968
- PRQR 2012
- Country
- MERC Canada
- PRQR Netherlands
- Employees
- MERC N/A
- PRQR N/A
- Industry
- MERC Paper
- PRQR Biotechnology: Pharmaceutical Preparations
- Sector
- MERC Basic Materials
- PRQR Health Care
- Exchange
- MERC Nasdaq
- PRQR Nasdaq
- Market Cap
- MERC 190.9M
- PRQR 224.4M
- IPO Year
- MERC 1987
- PRQR 2014
- Fundamental
- Price
- MERC $2.60
- PRQR $2.79
- Analyst Decision
- MERC Hold
- PRQR Strong Buy
- Analyst Count
- MERC 3
- PRQR 8
- Target Price
- MERC $4.67
- PRQR $8.88
- AVG Volume (30 Days)
- MERC 503.8K
- PRQR 646.0K
- Earning Date
- MERC 11-06-2025
- PRQR 11-07-2025
- Dividend Yield
- MERC 8.62%
- PRQR N/A
- EPS Growth
- MERC N/A
- PRQR N/A
- EPS
- MERC N/A
- PRQR N/A
- Revenue
- MERC $1,951,044,000.00
- PRQR $20,129,184.00
- Revenue This Year
- MERC N/A
- PRQR N/A
- Revenue Next Year
- MERC $13.33
- PRQR N/A
- P/E Ratio
- MERC N/A
- PRQR N/A
- Revenue Growth
- MERC N/A
- PRQR 8.65
- 52 Week Low
- MERC $2.37
- PRQR $1.07
- 52 Week High
- MERC $8.28
- PRQR $4.21
- Technical
- Relative Strength Index (RSI)
- MERC 43.70
- PRQR 58.26
- Support Level
- MERC $2.37
- PRQR $2.71
- Resistance Level
- MERC $2.72
- PRQR $2.99
- Average True Range (ATR)
- MERC 0.12
- PRQR 0.24
- MACD
- MERC 0.02
- PRQR 0.01
- Stochastic Oscillator
- MERC 47.66
- PRQR 65.56
About MERC Mercer International Inc.
Mercer International Inc is a forest products company with two reportable operating segments in pulp and solid wood. The pulp segment consists of the manufacture, sale, and distribution of pulp, electricity, and chemicals. The company has a geographical presence in the USA, Germany, China, and Other countries, where the majority of revenue is generated from the USA. The majority of the revenue is generated from the Pulp segment.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.